Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Maryland Diabetes Drug Improper Marketing Lawsuit

GlaxoSmithKline agreed to pay the State of Maryland $15 million to resolve allegations that the company engaged in improper marketing of the prescription diabetes drugs Avandia, Avandamet, and Avandaryl. The lawsuit alleged that GlaxoSmithKline falsely touted the drugs as superior to other diabetes medications. The lawsuit also alleged that the company withheld data showing that its drugs dramatically increase the risk of heart attack and other serious adverse effects.

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
12/17/2013
Contractors Involved Penalty
Total
GlaxoSmithKline $15,000,000
Further Information Released
Complaint (redacted) 12/20/2013
Maryland AG Press Release 12/17/2013
Settlement Agreement 12/16/2013

Federal Contractor Misconduct Database